Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenue $ 5,162 $ 3,188 $ 9,989 $ 5,566
Operating expenses:        
Research and development 25,786 14,796 45,815 29,365
General and administrative 5,520 5,133 11,260 10,282
Total operating expenses 31,306 19,929 57,075 39,647
Loss from operations (26,144) (16,741) (47,086) (34,081)
Interest income 12 32 24 416
Interest expense (969) (487) (1,937) (757)
Change in fair value of warrant liability 4,611   12,281  
Net loss applicable to common stockholders $ (22,490) $ (17,196) $ (36,718) $ (34,422)
Net loss per share applicable to common stockholders - basic and diluted $ (0.36) $ (0.38) $ (0.59) $ (0.77)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 62,859,500 45,699,277 62,123,658 44,811,638